(selection) Publications

Dr. Munoz about NK-1R in Cancer (2004 - today):

2025 - Cancers (Corresponding author)

Muñoz M, Rosso M. Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma. Cancers (Basel). 2025 Feb 4;17(3):520. doi: 10.3390/cancers17030520.

2023 - Journal of Clinical Medicine (co-corresponding author)

Robinson P, Rosso M, Muñoz M. Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients. J Clin Med. 2023 Mar 9;12(6):2135. doi: 10.3390/jcm12062135

2022 - Biomed Research International (corresponding author)

Muñoz MF, Argüelles S, Rosso M, Medina R, Coveñas R, Ayala A, Muñoz M. The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma. Biomed Res Int. 2022 Apr 4;2022:6291504. doi: 10.1155/2022/6291504.

2019 - Letters in Drug Design & Discovery (1st & corresponding author)

Neurokinin-1 Receptor Antagonists as Anticancer Drugs. Letters in Drug Design & Discovery 2019.DOI:10.2174/1570180816666190221091955

2019 - Molecular and Clinical Oncology (1st & corresponding author)

Muñoz M, Crespo JC, Crespo JP, Coveñas R. Neurokinin-1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report. Mol Clin Oncol. 2019 Jul;11(1):50-54. doi: 10.3892/mco.2019.1857.

2018 - Investigational New Drugs (corresponding author)

Molinos-Quintana A, Trujillo-Hacha P, Piruat JI, Bejarano-García JA, García-Guerrero E, Pérez-Simón JA, Muñoz M. Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists. Invest New Drugs. 2019 Feb;37(1):17-26. doi: 10.1007/s10637-018-0607-8.

2014 - Journal of Biosciences (1st & corresponding author)

Munoz M, Covenas R, Esteban F, Redondo M. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J Biosci. 2015 Jun;40(2):441-63. doi: 10.1007/s12038-015-9530-8.

2014 - International Journal of Oncology (1st & corresponding author)

Muñoz M, González-Ortega A, Salinas-Martín MV, Carranza A, Garcia-Recio S, Almendro V, Coveñas R. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer. Int J Oncol. 2014 Oct;45(4):1658-72. doi: 10.3892/ijo.2014.2565.

2014 - Amino Acids (1st & corresponding author)

Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in human pathology. Amino Acids. 2014 Jul;46(7):1727-50. doi: 10.1007/s00726-014-1736-9.

2010 - Investigational New Drug (1st & corresponding author)

Muñoz M, Rosso M. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Invest New Drugs. 2010 Apr;28(2):187-93. doi: 10.1007/s10637-009-9218-8.

2004 - Archives Italiennes de Biologie (1st & corresponding author)

Muñoz M, Pérez A, Coveñas R, Rosso M, Castro E. Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines. Arch Ital Biol. 2004 Mar;142(2):105-12.